FF:13143-140I2: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(5 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{f5samples | {{f5samples | ||
|DRA_sample_Accession=CAGE@SAMD00021779 | |DRA_sample_Accession=CAGE@SAMD00021779 | ||
|accession_numbers=CAGE;DRX023808;DRR026207;DRZ005459;DRZ006245 | |DRA_sample_Accession_RNASeq=sRNA-Seq@SAMD00021779 | ||
|accession_numbers=CAGE;DRX023808;DRR026207;DRZ005459;DRZ006245;DRZ010074;DRZ010738 | |||
|accession_numbers_RNASeq=sRNA-Seq;DRX037397;DRR041763;DRZ007372 | |||
|ancestors_in_anatomy_facet= | |ancestors_in_anatomy_facet= | ||
|ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000988,CL:0000764,CL:0000548,CL:0000763,CL:0002371,CL:0002242,CL:0000255,CL:0000765 | |ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000988,CL:0000764,CL:0000548,CL:0000763,CL:0002371,CL:0002242,CL:0000255,CL:0000765 | ||
Line 46: | Line 48: | ||
|library_id=CNhs12682 | |library_id=CNhs12682 | ||
|library_id_phase_based=2:CNhs12682 | |library_id_phase_based=2:CNhs12682 | ||
|microRNAs= | |||
|microRNAs_nn= | |||
|microRNAs_nonnovel_cage=http://fantom.gsc.riken.jp/5/suppl/De_Rie_et_al_2017/vis_viewer/#/mouse#cage;sample;13143 | |||
|microRNAs_nonnovel_srna=http://fantom.gsc.riken.jp/5/suppl/De_Rie_et_al_2016/vis_viewer/#/mouse#srna;sample;SRhi10062.ACTTGA.13143 | |||
|microRNAs_novel_cage=http://fantom.gsc.riken.jp/5/suppl/De_Rie_et_al_2017/vis_viewer_novel/#/mouse#cage;sample;13143 | |||
|microRNAs_novel_srna=http://fantom.gsc.riken.jp/5/suppl/De_Rie_et_al_2016/vis_viewer_novel/#/mouse#srna;sample;SRhi10062.ACTTGA.13143 | |||
|mm10bam=http://fantom.gsc.riken.jp/5/datafiles/reprocessed/mm10_v2/basic/mouse.timecourse.hCAGE/J2E%2520erythroblastic%2520leukemia%2520response%2520to%2520erythropoietin%252c%252024hr%252c%2520biol_rep2.CNhs12682.13143-140I2.mm10.nobarcode.bam | |mm10bam=http://fantom.gsc.riken.jp/5/datafiles/reprocessed/mm10_v2/basic/mouse.timecourse.hCAGE/J2E%2520erythroblastic%2520leukemia%2520response%2520to%2520erythropoietin%252c%252024hr%252c%2520biol_rep2.CNhs12682.13143-140I2.mm10.nobarcode.bam | ||
|mm10ctss=http://fantom.gsc.riken.jp/5/datafiles/reprocessed/mm10_v2/basic/mouse.timecourse.hCAGE/J2E%2520erythroblastic%2520leukemia%2520response%2520to%2520erythropoietin%252c%252024hr%252c%2520biol_rep2.CNhs12682.13143-140I2.mm10.nobarcode.ctss.bed.gz | |mm10ctss=http://fantom.gsc.riken.jp/5/datafiles/reprocessed/mm10_v2/basic/mouse.timecourse.hCAGE/J2E%2520erythroblastic%2520leukemia%2520response%2520to%2520erythropoietin%252c%252024hr%252c%2520biol_rep2.CNhs12682.13143-140I2.mm10.nobarcode.ctss.bed.gz | ||
Line 70: | Line 78: | ||
|rna_tube_id=140I2 | |rna_tube_id=140I2 | ||
|rna_weight_ug=40.02 | |rna_weight_ug=40.02 | ||
|rnaseq_library_id=SRhi10062.ACTTGA | |||
|sample_age= | |sample_age= | ||
|sample_category=time courses | |sample_category=time courses | ||
Line 94: | Line 103: | ||
|top_motifs= | |top_motifs= | ||
|xref= | |xref= | ||
|zenbu_report=https://fantom.gsc.riken.jp/zenbu/reports/#miRNA_expression_atlas_mouse;search_select_hide=table111:13143-140I2;search_select_hide=table117:13143-140I2 | |||
}} | }} |
Latest revision as of 18:52, 4 June 2020
Name: | J2E erythroblastic leukemia response to erythropoietin |
---|---|
Species: | Mouse (Mus musculus) |
Library ID: | CNhs12682 |
Sample type: | time courses |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
ZENBU report : | link |
ExpandAdditional information |
---|
ExpandCAGE Accession numbers |
---|
ExpandDownload raw sequence, BAM & CTSS |
---|
ExpandRNA-Seq Accession numbers |
---|
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
CNhs12682
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12682This sample isn't target for the analysis
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs12682This sample isn't target for the analysis
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs12682
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
EFO:0002091 biological replicate
FF:0000512 mouse J2E erythroblastic leukemia line 24hr after treatment with erythropoietin sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000988 (hematopoietic cell)
0000764 (erythroid lineage cell)
0000548 (animal cell)
0000763 (myeloid cell)
0002371 (somatic cell)
0002242 (nucleate cell)
0000255 (eukaryotic cell)
0000765 (erythroblast)
DOID: Disease
4 (disease)
0050686 (organ system cancer)
162 (cancer)
2531 (hematologic cancer)
14566 (disease of cellular proliferation)
0060083 (immune system cancer)
1240 (leukemia)
FF: FANTOM5
0000102 (sample by type)
0000003 (cell line sample)
0000101 (sample by species)
0000103 (mouse sample)
0000001 (sample)
0100737 (leukemia cell line sample)
0000401 (erythroblastic leukemia cell line sample)
0000350 (experimentally modified sample)
0000373 (24 hr sample)
0000337 (erythropoietin treatment sample)
0000403 (mouse J2E erythroblastic leukemia cell line sample)
0101035 (hematopoietic cell line sample)
0000512 (mouse J2E erythroblastic leukemia line 24hr after treatment with erythropoietin sample)
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
CL:0000049 (common myeloid progenitor)
CL:0000134 (mesenchymal cell)